ENZN
Enzon Pharmaceuticals Inc
Pharmaceutical company focused on PEGylation technology and cancer therapeutics
CUSIP: 293904108HealthcareUS1 holder
Total Value
$2.77M
Total Shares
5.90M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Icahn Capital LP
$2.77M5.90M sharesUnchanged